Purpose: Obesogenic environments in children, in particular excessive intake of sodium, generate hypertension, which is a major risk factor for chronic diseases. Methods: In all, 725 children, 379 boys and 373 girls, aged 8~9 years were recruited from seven elementary schools in Kuro-ku, Seoul. To evaluate whether or not obesity risk was modulated by salt-sensitive genes, Solute Carrier Familiy 12 member 3 (SLC12A3) was used as the target. After children were assigned into obese (BMI > 85 percentile) or non-obese groups, anthropometry, blood biochemistry, and dietary intakes were measured according to the genotypes GG (wild) or GA+AA (hetero+mutant). Results: Without gender differences, high TG and low HDLc were detected in the obese group compared to the non-obese group. Regardless of obesity, weight gain and blood pressure (BP) increased in the SLC12A3 GA+AA genotype rather than in the GG type. HDLc was associated with obesity risk without genotype difference. Odd ratios for risk of obesity were 15.57 (95% CI 2.192~110.654), 22.84 (95% CI 1.565~333.469), and 9.32 (95%CI 1.262~68.817) in boys and girls with GA+AA genotypes as sodium intake increased above 4,000 mg/day. Dietary calcium, sodium, folate, and vit C were associated with obesity risk according to gender or genotype differences. Since high folate intake reduced obesity risk in only boys with GG type. Risk for overweight and obesity increased in boys with GA+AA genotypes and dietary habits with high sodium and cholesterol and low folate. Conclusion: The A allele of SLC12A3 rs11643718 was sensitive to development of obesity in children as sodium intake increased.
. 반면, Non-OB OB P
1)
Non-OB OB 1.75 (0.77) < 0.001 1) P-value: Significantly differences of indicators among the 4 groups in total, boys and girls, NS: non-significant (p > 0.05) *Significantly differences between GG and GA+AA in non-OB or OB groups (*p < 0.05, **p < 0.01).
Significantly differences between non-OB and OB groups in GG or GA+AA genotype (p < 0.05). Abbreviation: WC, waist circumferences; BMI, body mass index; AST, aspartate transaminase; ALT, alanine transaminase; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triacylglycrides; HDLc, high-density lipoprotein cholesterol; LDLc, low-density lipoprotein cholesterol; FBS, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance (Fig. 3 
